dc.contributor.author | Ozkaya-Bayazit, Esen | |
dc.date.accessioned | 2021-03-03T21:15:15Z | |
dc.date.available | 2021-03-03T21:15:15Z | |
dc.date.issued | 2003 | |
dc.identifier.citation | Ozkaya-Bayazit E., "Specific site involvement in fixed drug eruption", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, cilt.49, sa.6, ss.1003-1007, 2003 | |
dc.identifier.issn | 0190-9622 | |
dc.identifier.other | av_5e337a74-bb3b-4107-9c1a-de95deb76122 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/65893 | |
dc.identifier.uri | https://doi.org/10.1016/s0190-9622(03)01588-3 | |
dc.description.abstract | A total of 105 patients with established fixed drug eruption (FDE) by oral provocation were evaluated with regard to a drug-related site involvement. Cotrimoxazole was the leading causative agent (63.8%), followed by naproxen sodium (23.8%), dipyrone (5.7%), oxicams (4.8%) and other rare causes (1.9%). Cotrimoxazole most frequently induced lesions on genital mucosa; naproxen and oxicams on lips; and dipyrone on trunk and extremities. Isolated FDE on male genitalia (n = 16) was exclusively because of cotrimoxazole. A highly significant association could be established between naproxen and FIDE on lips (chi-square = 28.3; corrected P = .000002). As this study represents the largest series of patients with naproxen-induced FIDE, we would suggest that naproxen should be considered as an important potential cause of FDE on lips. | |
dc.language.iso | eng | |
dc.subject | Dermatoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | DERMATOLOJİ | |
dc.title | Specific site involvement in fixed drug eruption | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | |
dc.contributor.department | İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü | |
dc.identifier.volume | 49 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 1003 | |
dc.identifier.endpage | 1007 | |
dc.contributor.firstauthorID | 55021 | |